Seroatlas · Human Serome Atlas

FA2H

Fatty acid 2-hydroxylase

Also known as: FA2H_HUMAN, FAAH, FAXDC1, FLJ25287, SPG35

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q7L5A8
Gene
FA2H
Ensembl
ENSG00000103089
Chromosome
16
Canonical length
372 aa
Protein class
Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins
Subcellular location
Nuclear membrane

OverviewNCBI Gene

This gene encodes a protein that catalyzes the synthesis of 2-hydroxysphingolipids, a subset of sphingolipids that contain 2-hydroxy fatty acids. Sphingolipids play roles in many cellular processes and their structural diversity arises from modification of the hydrophobic ceramide moiety, such as by 2-hydroxylation of the N-acyl chain, and the existence of many different head groups. Mutations in this gene have been associated with leukodystrophy dysmyelinating with spastic paraparesis with or without dystonia.[provided by RefSeq, Mar 2010]

Canonical amino-acid sequenceUniProt

372 residues, UniProt reviewed canonical sequence.

>Q7L5A8|FA2H
     1  MAPAPPPAAS FSPSEVQRRL AAGACWVRRG ARLYDLSSFV RHHPGGEQLL RARAGQDISA
    61  DLDGPPHRHS ANARRWLEQY YVGELRGEQQ GSMENEPVAL EETQKTDPAM EPRFKVVDWD
   121  KDLVDWRKPL LWQVGHLGEK YDEWVHQPVT RPIRLFHSDL IEGLSKTVWY SVPIIWVPLV
   181  LYLSWSYYRT FAQGNVRLFT SFTTEYTVAV PKSMFPGLFM LGTFLWSLIE YLIHRFLFHM
   241  KPPSDSYYLI MLHFVMHGQH HKAPFDGSRL VFPPVPASLV IGVFYLCMQL ILPEAVGGTV
   301  FAGGLLGYVL YDMTHYYLHF GSPHKGSYLY SLKAHHVKHH FAHQKSGFGI STKLWDYCFH
   361  TLTPEKPHLK TQ

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against FA2H can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Other membrane
Secreted
No
Transmembrane segments
4
Mean surface accessibility (rSASA)
0.32
Highest tissue expression
182 nTPM

Expression across tissuesHPA

Tissue

  • spinal cord: 182 nTPM
  • stomach: 58 nTPM
  • midbrain: 51 nTPM
  • hippocampal formation: 47 nTPM
  • basal ganglia: 29 nTPM
  • cerebral cortex: 28 nTPM

Single-cell type

  • urothelial cells: 808 nCPM
  • foveolar cells: 556 nCPM
  • oligodendrocytes: 472 nCPM
  • prostatic hillock cells: 353 nCPM
  • prostatic club cells: 257 nCPM
  • pancreatic acinar cells: 234 nCPM

Immune cell

  • memory B-cell: 0.6 nTPM
  • basophil: 0 nTPM
  • classical monocyte: 0 nTPM
  • eosinophil: 0 nTPM
  • gdT-cell: 0 nTPM
  • intermediate monocyte: 0 nTPM

Brain region

  • white matter: 360 nTPM
  • medulla oblongata: 262 nTPM
  • pons: 192 nTPM
  • basal ganglia: 171 nTPM
  • midbrain: 155 nTPM
  • cerebellum: 152 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about FA2H.

Disease | AllUniProt

Conditions FA2H is implicated in, by any mechanism.

Disease | GeneticClinVar

68 pathogenic / likely-pathogenic of 430 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.56
gnomAD pLI
0.15
gnomAD missense Z
0.46
DepMap mean gene effect
-0.09
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

  • heme binding
  • iron ion binding
  • 4-hydroxysphinganine ceramide fatty acyl 2-hydroxylase activity
  • fatty acid 2-hydroxylase activity
  • free fatty acid 2-hydroxylase activity

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads FA2H as an antibody target. Whether an autoantibody or antibody against FA2H could matter depends on whether native FA2H is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

FA2H is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label FA2H as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/FA2H. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...